论文部分内容阅读
哈药集团有限公司坚持不断优化产业资本投向 ,围绕市场需求搞技改 ,积极推进技术创新成果产业化 ,目前已形成六大系列产品生产基地。这“六大基地”是 :以哈药总厂为主的抗生素和半合成抗生素生产基地 ;以制药六厂、制药四厂为主的抗生素多门类制剂生产基地 ;以医药生物技术开
Harbin Pharmaceutical Group Co., Ltd. insists on continuously optimizing the industrial capital investment, carrying out technical reforms based on market demand, and actively promoting the industrialization of technological innovation achievements. At present, it has formed six production bases for series products. The “six bases” are: production bases for antibiotics and semi-synthetic antibiotics based on Kazakhstan Pharmaceutical Plant; production bases for antibiotics and multi-agents based on Sixth Pharmaceutical Factory and Fourth Pharmaceutical Factory; opened with medical biotechnology.